Shooting Cancer Highlights – UGT1A1 & DPYD: Safer chemotherapy starts with genotyping

DPYD Genotyping in Fluoropyrimidine Therapy: Reducing Toxicity, Improving Outcome Fluoropyrimidines such as 5-fluorouracil (5-FU), capecitabine, and tegafur are widely used in oncology, treating over 3.5 million patients annually—with 600,000 in Europe alone. Despite their effectiveness, these drugs carry a significant risk of toxicity: 10–40% of patients develop severe side effects (Grade 3–4) requiring hospitalisation and […]

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter

You are leaving the U.S. & Canada Research Use Only (RUO) area.

The content you are about to access is intended for other markets and may include products or information not available in the U.S. or Canada.

logo Diatech Pharmacogenetics
Select Your Region

Please select your region to access the content that is most relevant to your location and applicable regulations.